STRS Ohio’s Definium Therapeutics DFTX Stock Holding History

STRS Ohio’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.58M	Buy	33,500 +14,200	+74%	+$351K	0.01%	587
2026 Q1	$365K	Buy	+19,300	New	+$328K	﹤0.01%	1242
2022 Q2	–	Sell	-5,320	Closed	-$88K	–	2191
2022 Q1	$88K	Hold	5,320	–	–	﹤0.01%	1866
2021 Q4	$110K	Hold	5,320	–	–	﹤0.01%	1881
2021 Q3	$185K	Buy	5,320 +340	+7%	+$14.7K	﹤0.01%	1794
2021 Q2	$257K	Buy	+4,980	New	+$261K	﹤0.01%	1748

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

STRS Ohio's DFTX Position: Q2 2026 in Review

STRS Ohio increased its Definium Therapeutics (DFTX) stake by 74% in Q2 2026, buying an estimated $351K and bringing the position to 33,500 shares worth $1.58M. The position accounts for 0.01% of the portfolio, ranked #587.

STRS Ohio first reported a position in DFTX in Q2 2021 and has held it in 6 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

STRS Ohio held 33,500 shares of Definium Therapeutics worth $1.58M as of Q2 2026.
STRS Ohio bought 14,200 Definium Therapeutics shares in Q2 2026, an estimated $351K.
Definium Therapeutics made up 0.01% of STRS Ohio's portfolio in Q2 2026, its #587 holding.
STRS Ohio first reported a position in Definium Therapeutics in Q2 2021 and has held it in 6 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.